Calumet Specialty Products
CLMT
115 hedge funds and large institutions have $265M invested in Calumet Specialty Products in 2014 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 43 increasing their positions, 34 reducing their positions, and 18 closing their positions.
83% more call options, than puts
Call options by funds: $10.9M | Put options by funds: $5.96M
26% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 34
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
6% less capital invested
Capital invested by funds: $283M → $265M (-$18.4M)
7% less funds holding
Funds holding: 124 → 115 (-9)
44% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
+$9.07M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$6.3M |
| 3 |
TFMS
Trust & Fiduciary Management Services
Boston,
Massachusetts
|
+$5.35M |
| 4 |
SG Americas Securities
New York
|
+$3.11M |
| 5 |
SOAMC
Spirit of America Management Corp
Syosset,
New York
|
+$2.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NIM
NXG Investment Management
Dallas,
Texas
|
-$2.71M |
| 2 |
PM
Penbrook Management
New York
|
-$2.63M |
| 3 |
GI
Gradient Investments
Arden Hills,
Minnesota
|
-$2.47M |
| 4 |
JP Morgan Chase
New York
|
-$1.48M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.07M |
CLMT Hedge Fund Activity: Q3 2014 in Review
115 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Calumet Specialty Products (CLMT) for Q3 2014, worth a combined $265M — down 6.5% from $283M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of CLMT and 10 opened new positions — a net loss of 8 holders — while 34 trimmed existing stakes and 43 added.
The largest buyer was Weiss Multi-Strategy Advisers, opening a new position worth an estimated $9.07M. The largest seller was NXG Investment Management, exiting entirely with an estimated $2.71M sold.
- 115 institutional investors held Calumet Specialty Products (CLMT) as of Q3 2014, down from 124 in Q2 2014.
- Funds reported $265M of Calumet Specialty Products stock for Q3 2014, down 6.5% quarter-over-quarter.
- 10 funds opened new Calumet Specialty Products positions in Q3 2014 and 18 closed out, a net change of -8 holders.
- The largest Calumet Specialty Products buyer in Q3 2014 was Weiss Multi-Strategy Advisers, an estimated $9.07M added.
- The largest Calumet Specialty Products seller in Q3 2014 was NXG Investment Management, an estimated $2.71M sold.
Based on aggregated 13F filings for Q3 2014.